This is in line with others, showing that the protective role of IL-32 during the development of atherosclerosis is related to a single promoter single-nucleotide polymorphism (SNP) in IL-32, contributing to modified lipid profiles, especially in rheumatoid arthritis patients (33). This evidence concerns the gene IL32 and atherosclerosis.